Mycophenolic Acid

In the US, Mycophenolic Acid (mycophenolic acid systemic) is a member of the drug class selective immunosuppressants and is used to treat Dermatomyositis and Rejection Prophylaxis.

US matches:

• Mycophenolic Acid Delayed-Release Tablets


• Mycophenolic acid

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

L04AA06

CAS registry number (Chemical Abstracts Service)

0024280-93-1

Chemical Formula

C17-H20-O6

Molecular Weight

320

Therapeutic Categories

Antineoplastic antibacterial

Selective immunosuppressant

Chemical Name

4-Hexenoic acid, 6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-, (E)-

Foreign Names

• Acidum Mycophenolicum (Latin)
• Mycophenolsäure (German)
• Acide mycophénolique (French)
• Acido micofenolico (Spanish)

Generic Names

• Acide Mycophénolique (OS: DCF)
• Mycophenolic Acid (OS: BAN, USAN)
• Acidum mycophenolicum (IS)
• Lilly 68618 (IS: Lilly)
• MPA (IS)
• NSC 129185 (IS)
• Mycophenolate Mofetil (OS: USAN, BANM)
• ME-MPA (IS: Syntex)
• RS 61443 (IS: Syntex)
• Myclophenolas mofetil (PH: Ph. Eur. 6)
• Mycophenolate Mofetil (PH: BP 2010, Ph. Eur. 6, USP 32)
• Mycophenolic acid monosodium salt (IS)
• Mycophenolic monosodium salt (IS)
• Myxophenolic acid, sodium salt (IS)

Brand Names

• Mofetilmikofenolat Teva
  Teva, Slovenia



• Myfenax
  Teva, Slovenia



• Myfortic
  Novartis, South Africa



• Baxmune
  Ranbaxy, India



• Cellcept
  Chugai, Japan; Roche, United Arab Emirates; Roche, Argentina; Roche, Austria; Roche, Australia; Roche, Aruba; Roche, Bosnia & Herzegowina; Roche, Bangladesh; Roche, Belgium; Roche, Bahrain; Roche, Brazil; Roche, Botswana; Roche, Belarus; Roche, Canada; Roche, Switzerland; Roche, Chile; Roche, China; Roche, Colombia; Roche, Cuba; Roche, Cyprus; Roche, Czech Republic; Roche, Germany; Roche, Denmark; Roche, Ecuador; Roche, Estonia; Roche, Egypt; Roche, Spain; Roche, Finland; Roche, France; Roche, United Kingdom; Roche, Georgia; Roche, Ghana; Roche, Greece; Roche, Hong Kong; Roche, Croatia (Hrvatska); Roche, Hungary; Roche, Indonesia; Roche, Ireland; Roche, Israel; Roche, India; Roche, Iraq; Roche, Iran; Roche, Iceland; Roche, Italy; Roche, Jamaica; Roche, Jordan; Roche, Kenya; Roche, South Korea; Roche, Kuwait; Roche, Kazakhstan; Roche, Lebanon; Roche, Sri Lanka; Roche, Lithuania; Roche, Luxembourg; Roche, Morocco; Roche, Macedonia; Roche, Mauritius; Roche, Malawi; Roche, Mexico; Roche, Malaysia; Roche, Namibia; Roche, Nigeria; Roche, Netherlands; Roche, Norway; Roche, Nepal; Roche, New Zealand; Roche, Oman; Roche, Peru; Roche, Philippines; Roche, Pakistan; Roche, Poland; Roche, Portugal; Roche, Qatar; Roche, Romania; Roche, Serbia; Roche, Russian Federation; Roche, Saudi Arabia; Roche, Sudan; Roche, Singapore; Roche, Slovenia; Roche, Slovakia; Roche, Syria; Roche, Thailand; Roche, Tunisia; Roche, Turkey; Roche, Trinidad & Tobago; Roche, Taiwan; Roche, Tanzania; Roche, Ukraine; Roche, Uganda; Roche, United States; Roche, Uruguay; Roche, Uzbekistan; Roche, Venezuela; Roche, Vietnam; Roche, South Africa; Roche, Zambia; Roche, Zimbabwe; Roche Diagnostic, Algeria



• CellCept
  Roche, Sweden



• Linfonex
  Farmindustria, Peru; Recalcine, Ecuador; Tadt, Chile



• MMF
  Medis, Tunisia



• Mycocell
  Biotoscana, Colombia



• Mycophenolate Mofetil Sandoz
  Sandoz, Switzerland; Sandoz, Estonia; Sandoz, Latvia



• Mycophenolate Mofetil
  Accord, United States; Apotex, United States; Endo, United States; Mylan, United States; Roxane, United States; Sandoz, United States; Teva USA, United States; Zydus, United States



• Myfenax
  Teva Pharma, Switzerland



• Myfetil
  Specifar, Greece



• Mykofenolat Mofetil Sandoz
  Sandoz, Slovakia



• Trixin
  Pliva, Croatia (Hrvatska)



• Myfortic
  Dr. Fisher, Netherlands; EU-Pharma, Netherlands; Euro, Netherlands; Medcor, Netherlands; Novartis, Austria; Novartis, Australia; Novartis, Belgium; Novartis, Brazil; Novartis, Canada; Novartis, Switzerland; Novartis, Chile; Novartis, Colombia; Novartis, Czech Republic; Novartis, Germany; Novartis, Denmark; Novartis, Ecuador; Novartis, Estonia; Novartis, Spain; Novartis, Finland; Novartis, France; Novartis, United Kingdom; Novartis, Greece; Novartis, Hong Kong; Novartis, Croatia (Hrvatska); Novartis, Hungary; Novartis, Indonesia; Novartis, Ireland; Novartis, Israel; Novartis, Iceland; Novartis, Italy; Novartis, Lithuania; Novartis, Luxembourg; Novartis, Latvia; Novartis, Malta; Novartis, Mexico; Novartis, Malaysia; Novartis, Netherlands; Novartis, Norway; Novartis, Oman; Novartis, Philippines; Novartis, Poland; Novartis, Portugal; Novartis, Romania; Novartis, Serbia; Novartis, Russian Federation; Novartis, Sweden; Novartis, Singapore; Novartis, Slovenia; Novartis, Slovakia; Novartis, Thailand; Novartis, Turkey; Novartis, Taiwan; Novartis, United States; Novartis, Venezuela; Novartis, Vietnam

International Drug Name Search

Glossary

BAN	British Approved Name
BANM	British Approved Name (Modified)
DCF	Dénomination Commune Française
IS	Inofficial Synonym
OS	Official Synonym
PH	Pharmacopoeia Name
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.